The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kugler, A., Stuhler, G., Walden, P., Zöller, G., Zobywalski, A., Brossart, P., Trefzer, U., Ullrich, S., Müller, C. A., Becker, V., et al. (2000) · Nature Medicine · doi:10.1038/73193 · Cited by 639
RetractedInterferon-γ: an overview of signals, mechanisms and functions
Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120
Cancer immunotherapy: moving beyond current vaccines
Rosenberg, S. A., Yang, J. C., & Restifo, N. P. (2004) · Nature Medicine · doi:10.1038/nm1100 · Cited by 2,972
Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., & Schadendorf, D. (1998) · Nature Medicine · doi:10.1038/nm0398-328 · Cited by 2,862
Design and development of polymers for gene delivery
Pack, D. W., Hoffman, A. S., Pun, S., & Stayton, P. S. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1775 · Cited by 2,568
CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., et al. (1997) · Science · doi:10.1126/science.278.5343.1626 · Cited by 2,400
Jain, R. A. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00115-0 · Cited by 2,214
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. (2003) · Science · doi:10.1126/science.1078231 · Cited by 1,997
Proliferating dendritic cell progenitors in human blood.
Romani, N., Gruner, S., Brang, D., Kämpgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P. O., Steinman, R. M., & Schuler, G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.83 · Cited by 1,840
Dieu, M.-C., Vanbervliet, B., Vicari, A., Bridon, J.-M., Oldham, E., Aït-Yahia, S., Brière, F., Zlotnik, A., Lebecque, S., & Caux, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.373 · Cited by 1,425
CELL BIOLOGY OF ANTIGEN PROCESSING IN VITRO AND IN VIVO
Trombetta, E. S., & Mellman, I. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104538 · Cited by 1,173
Phagocytosis of Microbes: Complexity in Action
Underhill, D. M., & Ozinsky, A. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.103001.114744 · Cited by 1,124
Panyam, J., Zhou, W., Prabha, S., Sahoo, S. K., & Labhasetwar, V. (2002) · The FASEB Journal · doi:10.1096/fj.02-0088com · Cited by 1,044
CD1: Antigen Presentation and T Cell Function
Brigl, M., & Brenner, M. B. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104608 · Cited by 1,035
Mundargi, R. C., Babu, V. R., Rangaswamy, V., Patel, P., & Aminabhavi, T. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.013 · Cited by 1,025
T-cell priming by type-1and type-2 polarized dendritic cells: the concept of a third signal
Kaliński, P., Hilkens, C. M. U., Wierenga, E. A., & Kapsenberg, M. L. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01547-9 · Cited by 933
Cross-Presentation, Dendritic Cells, Tolerance and Immunity
Heath, W. R., & Carbone, F. R. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.47 · Cited by 882
High-Efficiency Intracellular Magnetic Labeling with Novel Superparamagnetic-Tat Peptide Conjugates
Josephson, L., Tung, C.-H., Moore, A., & Weissleder, R. (1999) · Bioconjugate Chemistry · doi:10.1021/bc980125h · Cited by 882
Maturation Stages of Mouse Dendritic Cells in Growth Factor–dependent Long-Term Cultures
Winzler, C., Rovere, P., Rescigno, M., Granucci, F., Penna, G., Adorini, L., Zimmermann, V. S., Davoust, J., & Ricciardi-Castagnoli, P. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.2.317 · Cited by 849
Toll-dependent selection of microbial antigens for presentation by dendritic cells
Blander, J. M., & Medzhitov, R. (2006) · Nature · doi:10.1038/nature04596 · Cited by 840
Banchereau, J., Palucka, A. K., Dhodapkar, M. V., Burkeholder, S. B., Taquet, N., Rolland, A., Taquet, S., Coquery, S., Wittkowski, K. M., Bhardwaj, N., et al. (2001) · PubMed · Cited by 805
ER–phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells
Guermonprez, P., Saveanu, L., Kleijmeer, M., Davoust, J., van Endert, P., & Amigorena, S. (2003) · Nature · doi:10.1038/nature01911 · Cited by 753
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting
Tacken, P. J., de Vries, I. J. M., Torensma, R., & Figdor, C. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2173 · Cited by 750
PLGA Nanoparticles in Drug Delivery: The State of the Art;
Bala, I., Hariharan, S., & Kumar, M. R. (2004) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v21.i5.20 · Cited by 739
Miller, R. A., Brady, J. M., & Cutright, D. E. (1977) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820110507 · Cited by 722
Phagosomes are competent organelles for antigen cross-presentation
Houde, M., Bertholet, S., Gagnon, E., Brunet, S., Goyette, G., Laplante, A., Princiotta, M. F., Thibault, P., Sacks, D., & Desjardins, M. (2003) · Nature · doi:10.1038/nature01912 · Cited by 699
Endoplasmic Reticulum-Mediated Phagocytosis Is a Mechanism of Entry into Macrophages
Gagnon, E., Duclos, S., Rondeau, C., Chevet, E., Cameron, P. H., Steele-Mortimer, O., Paiement, J., Bergeron, J. J. M., & Desjardins, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00797-3 · Cited by 683
Immunotherapy of Tumors with Autologous Tumor-Derived Heat Shock Protein Preparations
Tamura, Y., Peng, P., Liu, K., Daou, M., & Srivastava, P. K. (1997) · Science · doi:10.1126/science.278.5335.117 · Cited by 680
Natural-killer cells and dendritic cells: “l'union fait la force”
Walzer, T., Dalod, M., Robbins, S. H., Zitvogel, L., & Vivier, E. (2005) · Blood · doi:10.1182/blood-2005-03-1154 · Cited by 634
Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes
Bousso, P., & Robey, E. (2003) · Nature Immunology · doi:10.1038/ni928 · Cited by 625
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
Fong, L., Hou, Y., Rivas, A., Benike, C., Yuen, A., Fisher, G. A., Davis, M. M., & Engleman, E. G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141226398 · Cited by 541
ER Quality Control: The Cytoplasmic Connection
Kopito, R. R. (1997) · Cell · doi:10.1016/s0092-8674(00)81881-4 · Cited by 518
(2003) · PubMed · Cited by 477
The role of chemokines in linking innate and adaptive immunity
Luster, A. D. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00308-9 · Cited by 474
Improving protein therapeutics with sustained-release formulations
Putney, S. D., & Burke, P. A. (1998) · Nature Biotechnology · doi:10.1038/nbt0298-153 · Cited by 460
Fields, R. C., Shimizu, K., & Mulé, J. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9482 · Cited by 454
Heikenwalder, M., Polymenidou, M., Junt, T., Sigurdson, C., Wagner, H., Akira, S., Zinkernagel, R., & Aguzzi, A. (2004) · Nature Medicine · doi:10.1038/nm987 · Cited by 449
Biodegradable Polymers for Protein and Peptide Drug Delivery
Gombotz, W. R., & Pettit, D. K. (1995) · Bioconjugate Chemistry · doi:10.1021/bc00034a002 · Cited by 448
Davis, I. D., Chen, W., Jackson, H., Parente, P., Shackleton, M., Hopkins, W., Chen, Q., Dimopoulos, N., Luke, T., Murphy, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403572101 · Cited by 440
CD4 cells can be more efficient at tumor rejection than CD8 cells
Perez-Diez, A., Joncker, N. T., Choi, K., Chan, W. F. N., Anderson, C. C., Lantz, O., & Matzinger, P. (2007) · Blood · doi:10.1182/blood-2006-10-051318 · Cited by 437
Randomized Phase IIB Trial of BLP25 Liposome Vaccine in Stage IIIB and IV Non–Small-Cell Lung Cancer
Butts, C., Murray, N., Maksymiuk, A., Goss, G., Marshall, E., Soulières, D., Cormier, Y., Ellis, P., Price, A., Sawhney, R., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.13.011 · Cited by 428
Yang, Y., Huang, C.-T., Huang, X., & Pardoll, D. M. (2004) · Nature Immunology · doi:10.1038/ni1059 · Cited by 425
Chang, D. H., Osman, K., Connolly, J., Kukreja, A., Krasovsky, J., Pack, M., Hutchinson, A., Geller, M., Liu, N., Annable, R., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042592 · Cited by 415
Targeting dendritic cells with biomaterials: developing the next generation of vaccines
Reddy, S. T., Swartz, M. A., & Hubbell, J. A. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.10.005 · Cited by 406
Biodegradable microspheres as a vaccine delivery system
Eldridge, J. H., Staas, J. K., Meulbroek, J. A., McGhee, J. R., Tice, T. R., & Gilley, R. M. (1991) · Molecular Immunology · doi:10.1016/0161-5890(91)90076-v · Cited by 399
Shen, L., Sigal, L. J., Boes, M., & Rock, K. L. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.004 · Cited by 391
Ackerman, A. L., Kyritsis, C., Tampé, R., & Cresswell, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1735556100 · Cited by 383
Mackensen, A., Herbst, B., Chen, J.-L., K�hler, G., Noppen, C., Herr, W., Spagnoli, G. C., Cerundolo, V., & Lindemann, A. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000501)86:3<385::aid-ijc13>3.0.co;2-t · Cited by 345
PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination
Garinot, M., Fiévez, V., Pourcelle, V., Stoffelbach, F., des Rieux, A., Plapied, L., Theate, I., Freichels, H., Jérôme, C., Marchand-Brynaert, J., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.021 · Cited by 331
Biodegradable microspheres as controlled-release tetanus toxoid delivery systems
Alonso, M. J., Gupta, R. K., Min, C., Siber, G. R., & Langer, R. (1994) · Vaccine · doi:10.1016/0264-410x(94)90092-2 · Cited by 313
van Elsas, A., Sutmuller, R. P. M., Hurwitz, A. A., Ziskin, J., Villasenor, J., Medema, J.-P., Overwijk, W. W., Restifo, N. P., Melief, C. J. M., Offringa, R., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.481 · Cited by 309
Morse, M. A., Deng, Y., Coleman, D., Hull, S., Kitrell-Fisher, E., Nair, S. K., Schlom, J., Ryback, M. E., & Lyerly, H. K. (1999) · PubMed · Cited by 300
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy
Demento, S. L., Eisenbarth, S. C., Foellmer, H. G., Platt, C., Caplan, M. J., Mark Saltzman, W., Mellman, I., Ledizet, M., Fikrig, E., Flavell, R. A., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.034 · Cited by 290
Schlosser, E., Mueller, M., Fischer, S., Basta, S., Busch, D. H., Gander, B., & Groettrup, M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.01.030 · Cited by 262
Wang, D., Robinson, D. R., Kwon, G. S., & Samuel, J. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00099-6 · Cited by 256
Hamdy, S., Molavi, O., Ma, Z., Haddadi, A., Alshamsan, A., Gobti, Z., Elhasi, S., Samuel, J., & Lavasanifar, A. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.035 · Cited by 252
Self-citationPinilla-Ibarz, J., Cathcart, K., Korontsvit, T., Soignet, S., Bocchia, M., Caggiano, J., Lai, L., Jimenez, J., Kolitz, J., & Scheinberg, D. A. (2000) · Blood · doi:10.1182/blood.v95.5.1781.005k46_1781_1787 · Cited by 247
Elamanchili, P., Diwan, M., Cao, M., & Samuel, J. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.12.032 · Cited by 246
Zaks, K., Jordan, M., Guth, A., Sellins, K., Kedl, R., Izzo, A., Bosio, C., & Dow, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7335 · Cited by 242
Warger, T., Osterloh, P., Rechtsteiner, G., Fassbender, M., Heib, V., Schmid, B., Schmitt, E., Schild, H., & Radsak, M. P. (2006) · Blood · doi:10.1182/blood-2005-10-4015 · Cited by 242
Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells
Fehervari, Z. (2004) · International Immunology · doi:10.1093/intimm/dxh178 · Cited by 221
Degradation rates of polymers and copolymers of polylactic and polyglycolic acids
Cutright, D. E., Perez, B., Beasley, J. D., Larson, W. J., & Posey, W. R. (1974) · Oral Surgery, Oral Medicine, Oral Pathology · doi:10.1016/0030-4220(74)90171-6 · Cited by 213
Vaccines that facilitate antigen entry into dendritic cells
Gamvrellis, A., Leong, D., Hanley, J. C., Xiang, S. D., Mottram, P., & Plebanski, M. (2004) · Immunology & Cell Biology · doi:10.1111/j.0818-9641.2004.01271.x · Cited by 211
Devulder, B. (1994) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(05)82117-4 · Cited by 208
The Transporter Associated With Antigen Processing: Function and Implications in Human Diseases
Lankat-Buttgereit, B., & Tampé, R. (2002) · Physiological Reviews · doi:10.1152/physrev.00025.2001 · Cited by 202
Kubo, T., Hatton, R. D., Oliver, J., Liu, X., Elson, C. O., & Weaver, C. T. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7249 · Cited by 201
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
WAECKERLEMEN, Y., & GROETTRUP, M. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.007 · Cited by 196
Uptake of poly(D,L‐lactic‐co‐glycolic acid) microspheres by antigen‐presenting cells in vivo
Newman, K. D., Elamanchili, P., Kwon, G. S., & Samuel, J. (2002) · Journal of Biomedical Materials Research · doi:10.1002/jbm.10019 · Cited by 195
Chong, C. S. W., Cao, M., Wong, W. W., Fischer, K. P., Addison, W. R., Kwon, G. S., Tyrrell, D. L., & Samuel, J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.014 · Cited by 191
Goldszmid, R. S., Idoyaga, J., Bravo, A. I., Steinman, R., Mordoh, J., & Wainstok, R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5940 · Cited by 187
Schuster, M., Nechansky, A., & Kircheis, R. (2006) · Biotechnology Journal · doi:10.1002/biot.200500044 · Cited by 179
Diwan, M. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00275-4 · Cited by 177
FRAZER, I., QUINN, M., NICKLIN, J., TAN, J., PERRIN, L., NG, P., OCONNOR, V, WHITE, O., WENDT, N., & MARTIN, J. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.05.013 · Cited by 176
L-BLP25: A Peptide Vaccine Strategy in Non–Small Cell Lung Cancer
Sangha, R., & Butts, C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0213 · Cited by 173
Audran, R., Peter, K., Dannull, J., Men, Y., Scandella, E., Groettrup, M., Gander, B., & Corradin, G. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00521-2 · Cited by 168
Lutsiak, M. E. C., Robinson, D. R., Coester, C., Kwon, G. S., & Samuel, J. (2002) · Pharmaceutical Research · doi:10.1023/a:1020452531828 · Cited by 163
Song, R., & Harding, C. V. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.11.4182 · Cited by 162
“Pathogen-Mimicking” Nanoparticles for Vaccine Delivery to Dendritic Cells
Elamanchili, P., Lutsiak, C. M. E., Hamdy, S. I., Diwan, M., & Samuel, J. (2007) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31802cf3e3 · Cited by 159
Self-citationKamath, A. T., Sheasby, C. E., & Tough, D. F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.767 · Cited by 155
Antigen co‐encapsulated with adjuvants efficiently drive protective T cell immunity
Heit, A., Schmitz, F., Haas, T. L., Busch, D. H., & Wagner, H. (2007) · European Journal of Immunology · doi:10.1002/eji.200737169 · Cited by 136
Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity
Nixon, D. F., Hioe, C. E., Chen, P., Bian, Z., Kuebler, P., Li, M.-L., Qiu, H., Li, X.-M., Singh, M., Richardson, J. L., et al. (1996) · Vaccine · doi:10.1016/s0264-410x(96)00099-0 · Cited by 133
Garg, S., Oran, A. E., Wajchman, J., Sasaki, S., Maris, C. H., Kapp, J. A., & Jacob, J. (2003) · Nature Immunology · doi:10.1038/ni962 · Cited by 127
Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency
Kazzaz, J., Singh, M., Ugozzoli, M., Chesko, J., Soenawan, E., & O’Hagan, D. T. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.10.010 · Cited by 120
Diwan, M., Elamanchili, P., Lane, H. C., Gainer, A. L., & Samuel, J. (2003) · Journal of drug targeting · doi:10.1080/10611860410001670026 · Cited by 119
Dose Sparing of CpG Oligodeoxynucleotide Vaccine Adjuvants by Nanoparticle Delivery
Diwan, M., Elamanchili, P., Cao, M., & Samuel, J. (2004) · Current Drug Delivery · doi:10.2174/1567201043334597 · Cited by 118
Pandha, H., Rigg, A. S., John, J., & Lemoine, N. R. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03289.x · Cited by 113
Improving vaccines by targeting antigens to dendritic cells
Shortman, K., Lahoud, M. H., & Caminschi, I. (2009) · Experimental & Molecular Medicine · doi:10.3858/emm.2009.41.2.008 · Cited by 104
Tumour prevention and rejection with recombinant vaccinia
Lathe, R., Kiény, M. P., GERLINGER, P., Clertant, P., Guizani, I., Cuzin, F., & Chambon, P. (1987) · Nature · doi:10.1038/326878a0 · Cited by 103
Bernards, R., Destree, A. T., McKenzie, S. J., Gordon, E., Weinberg, R. A., & Panicali, D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6854 · Cited by 98
Targeting Vaccines to Dendritic Cells
Foged, C., Sundblad, A., & Hovgaard, L. (2002) · Pharmaceutical Research · doi:10.1023/a:1014474414097 · Cited by 96
Biodegradable polymers for the sustained release of peptides
Hutchinson, F., & Furr, B. J. A. (1985) · Biochemical Society Transactions · doi:10.1042/bst0130520 · Cited by 96
Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses
Lutsiak, M. E. C., Kwon, G. S., & Samuel, J. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.6.0004 · Cited by 89
Osman, Y., Takahashi, M., Zheng, Z., Koike, T., Toba, K., Liu, A., Furukawa, T., Aoki, S., & Aizawa, Y. (1999) · Leukemia · doi:10.1038/sj.leu.2401311 · Cited by 88
Challenges facing adjuvants for cancer immunotherapy
Mesa, C., & Fernandez, L. E. (2004) · Immunology and Cell Biology · doi:10.1111/j.0818-9641.2004.01279.x · Cited by 86
Passive Antibody Therapies: Progress and Continuing Challenges
Casadevall, A. (1999) · Clinical Immunology · doi:10.1006/clim.1999.4768 · Cited by 86
Steitz, J., Brück, J., Knop, J., & Tüting, T. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301521 · Cited by 86
Newman, K. D., Samuel, J., & Kwon, G. S. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00142-9 · Cited by 83
Poly(I:C) coated PLGA microparticles induce dendritic cell maturation
Wischke, C., Zimmermann, J., WESSINGER, B., SCHENDLER, A., BORCHERT, H., Peters, J. H., Neßelhut, T., & Lorenzen, D. R. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.08.039 · Cited by 83
Gene-based strategies for the immunotherapy of cancer
Tüting, T., Storkus, W. J., & Lotze, M. T. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050133 · Cited by 79
Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancer
Pinzón‐Charry, A., Ho, C. S. K., Maxwell, T., McGuckin, M. A., Schmidt, C., Furnival, C. M., Pyke, C., & López, J. A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604018 · Cited by 78
Chang, M. (2003) · Liver International · doi:10.1034/j.1478-3231.2003.00865.x · Cited by 77
Novel Approaches to Controlled-Release Antigen Delivery
Cohen, S., Alonso, M. J., & Langer, R. (1994) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300014045 · Cited by 77
Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation
Murshid, A., Gong, J., & Calderwood, S. K. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.7.1019 · Cited by 77
Cassaday, R. D., Sondel, P. M., King, D. M., Macklin, M. D., Gan, J., Warner, T. F., Zuleger, C., Bridges, A. J., Schalch, H., Kim, K. M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2039 · Cited by 77
Zanoni, I., Foti, M., Ricciardi‐Castagnoli, P., & Granucci, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.286 · Cited by 71
Newman, K. D., Sosnowski, D. L., Kwon, G. S., & Samuel, J. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980070s · Cited by 69
Promising particle-based vaccines in cancer therapy
Xiang, S. D., Scalzo‐Inguanti, K., Minigo, G., Park, A. J., Hardy, C. L., & Plebanski, M. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.7.1103 · Cited by 61
A high-throughput microparticle microarray platform for dendritic cell-targeting vaccines
Acharya, A. P., Clare-Salzler, M. J., & Keselowsky, B. G. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.04.032 · Cited by 59
Kempf, M., Mandal, B., Jilek, S., Thiele, L., Vörös, J., Textor, M., Merkle, H. P., & Walter, E. (2003) · Journal of drug targeting · doi:10.1080/1061186031000072978 · Cited by 58
Toll-like Receptor Ligands Energize Peptide Vaccines through Multiple Paths
Celis, E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1652 · Cited by 52
Cross-presentation: inducing CD8 T cell immunity and tolerance
Kurts, C. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000108 · Cited by 51
Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology
Román, B. S., Irache, J. M., GOMEZ, S., Tsapis, N., Gamazo, C., & Espuelas, S. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.03.015 · Cited by 51
Uchida, T., & Shigeru, G. O. T. O. (1994) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.17.1272 · Cited by 51
Biodegradable microspheres containing group B Streptococcus vaccine: Immune response in mice
Hunter, S. K., Andracki, M. E., & Krieg, A. Μ. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.117658 · Cited by 41
Onaitis, M. W., Kalady, M. F., Pruitt, S. K., & Tyler, D. S. (2002) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(02)00027-3 · Cited by 34
Cancer immunotherapy using cells modified with cytokine genes.
Kowalczyk, D. W., Wysocki, P. J., & Mackiewicz, A. A. (2003) · Acta Biochimica Polonica · doi:10.18388/abp.2003_3655 · Cited by 31
Effects of the Tumor Microenvironment on the Efficacy of Tumor Immunotherapy
Neeson, P. J., & Paterson, Y. Y. W. (2006) · Immunological Investigations · doi:10.1080/08820130600755009 · Cited by 22
Cancer vaccines: a new frontier in prevention and treatment.
Giarelli, E. (2007) · PubMed · Cited by 22
Prophylactic Human Papillomavirus Vaccination: A Breakthrough in Primary Cervical Cancer Prevention
García, F., & Saslow, D. (2007) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2007.09.007 · Cited by 12
Cited by
Chen, Q., Xu, L., Liang, C., Wang, C., Peng, R., & Liu, Z. (2016) · Nature Communications · doi:10.1038/ncomms13193 · Cited by 1,596
Zhao, L., Seth, A., Wibowo, N., Zhao, C.-X., Mitter, N., Yu, C., & Middelberg, A. P. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.11.069 · Cited by 919
Elmowafy, E. M., Tiboni, M., & Soliman, M. E. (2019) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-019-00439-x · Cited by 621
Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics
Ding, D., & Zhu, Q. (2018) · Materials Science and Engineering: C · doi:10.1016/j.msec.2017.12.036 · Cited by 386
Nanotechnology for COVID-19: Therapeutics and Vaccine Research
Chauhan, G., Madou, M. J., Kalra, S., Chopra, V., Ghosh, D., & Martinez-Chapa, S. O. (2020) · ACS Nano · doi:10.1021/acsnano.0c04006 · Cited by 385
Metadata
- Authors
- Hamdy, S., Haddadi, A., Hung, R. W., & Lavasanifar, A.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 63
- Issue
- 10-11
- Pages
- 943-955
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2034029599
- Cited by
- 298
- References
- 119
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.